Trial Profile
Safety and efficacy of dasatinib in patients with chronic myeloid leukemia: A multicentre real-life study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 03 Jun 2016 New trial record